François Labrousse

François Labrousse

Auto-generated profile, based on publicly available information

François Labrousse

Department of Pathology, Dupuytren University Hospital, Limoges, France

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2009 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
ADAnne Durand
Anne Durand
FLFrançois Labrousse
François Labrousse
AJAnne Jouvet
Anne Jouvet
LBLuc Bauchet
Luc Bauchet
MKMichel Kalamaridès
Michel Kalamaridès
JGJacques Guyotat
Jacques Guyotat

25 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VLVirginie F Labrousse
Virginie F Labrousse
ANAgnès Nadjar
Agnès Nadjar
CJCorinne Joffre
Corinne Joffre
LCLaurence Costes
Laurence Costes
AAAgnès Aubert
Agnès Aubert
SLSophie Layé
Sophie Layé
Regular consumption of food enriched in omega3 polyunsaturated fatty acids (ω3 PUFAs) has been shown to reduce risk of cognitive decline in elderly, and possibly development of Alzheimer's disease. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are the most likely active components of ω3-rich PUFAs diets in the brain. We therefore hypothesized that exposing mice to a DHA and EPA enriched diet may reduce neuroinflammation and protect against memory impairment in aged mice. For this purpose, mice were exposed to a control diet throughout life and were further submitted to a diet enriched in EPA and DHA during 2 additional months. Cytokine expression together with a thorough analysis of astrocytes morphology assessed by a 3D reconstruction was measured in the hippocampus of young (3-month-old) and aged (22-month-old) mice. In addition, the effects of EPA and DHA on spatial memory and associated Fos activation in the hippocampus were assessed. We showed that a 2-month EPA/DHA treatment increased these long-chain ω3 PUFAs in the brain, prevented cytokines expression and astrocytes morphology changes in the hippocampus and restored spatial memory deficits and Fos-associated activation in the hippocampus of aged mice. Collectively, these data indicated that diet-induced accumulation of EPA and DHA in the brain protects against neuroinflammation and cognitive impairment linked to aging, further reinforcing the idea that increased EPA and DHA intake may provide protection to the brain of aged subjects.

2 April 2010 in Neuro-Oncology
Verified
Journal Article
Closed access
LBLuc Bauchet
Luc Bauchet
HMH. Mathieu-Daude
H. Mathieu-Daude
PFP. Fabbro-Peray
P. Fabbro-Peray
VRV. Rigau
V. Rigau
MFM. Fabbro
M. Fabbro
JHJ. Honnorat
J. Honnorat
This report, an audit requested by the French government, describes oncological patterns of care, prognostic factors, and survival for patients with newly diagnosed and histologically confirmed glioblastoma multiforme (GBM) in France. The French Brain Tumor DataBase, which is a national multidisciplinary (neurosurgeons, neuropathologists, radiotherapists, neurooncologists, epidemiologists, and biostatisticians) network, prospectively collected initial data for the cases of GBM in 2004, and a specific data card was used to retrospectively collect data on the management and follow-up care of these patients between January 1, 2004, and December 1, 2006. We recorded 952 cases of GBM (male/female ratio 1.6, median age 63.9 years, mean preoperative Karnofsky performance status [KPS] 79). Surgery consisted of resection (RS; n = 541) and biopsy (n = 411); 180 patients did not have subsequent oncological treatment. After surgery, first-line treatment (n = 772) consisted of radiotherapy (RT) and temozolomide (TMZ) concomitant +/- adjuvant in 314 patients, RT alone in 236 patients, chemotherapy (CT) alone in 157 patients, and other treatment modalities in 65 patients. Median overall survival was 286 days (95% CI, 266-314) and was significantly affected by age, KPS, and tumor location. Median survival (days, 95% CI) associated with these main strategies, when analyzed by a surgical group, were as follows: RS + RT-TMZ((n=224)): 476 (441-506), biopsy + RT-TMZ((n=90)): 329 (301-413), RS + RT((n=147)): 363 (331-431), biopsy + RT((n=89)): 178 (153-237), RS + CT((n=61)): 245 (190-361), biopsy + CT((n=96)): 244 (198-280), and biopsy only((n=118)): 55 (46-71). This study illustrates the usefulness of a national brain tumor database. To our knowledge, this work is the largest report of recent GBM management in Europe.

1 May 1998 in Journal of Hepatology
Verified
Journal Article
Closed access
MMMichel-Henry Mendler
Michel-Henry Mendler
PBPhilippe Bouillet
Philippe Bouillet
ASAnne Le Sidaner
Anne Le Sidaner
ELEric Lavoine
Eric Lavoine
FLFrançois Labrousse
François Labrousse
BPBernard Pillegand
Bernard Pillegand

20 November 2008 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
LBLuc Bauchet
Luc Bauchet
VRValérie Rigau
Valérie Rigau
HMHélène Mathieu-Daudé
Hélène Mathieu-Daudé
PFPascale Fabbro-Peray
Pascale Fabbro-Peray
GPGilles Palenzuela
Gilles Palenzuela
AFAssociation des Neuro-Oncologues d’Expression Française
Association des Neuro-Oncologues d’Expression Française

15 March 2016 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
DFDominique Figarella-Branger
Dominique Figarella-Branger
ELEmmanuèle Lechapt-Zalcman
Emmanuèle Lechapt-Zalcman
ETEmeline Tabouret
Emeline Tabouret
SJStephanie Jünger
Stephanie Jünger
APAndré Maues de Paula
André Maues de Paula
TPTorsten Pietsch
Torsten Pietsch
Clear cell ependymoma is one of the 4 main histological subtypes of ependymomas defined by the World Health Organization (WHO) classification of tumors of the CNS. DNA methylation profiling can distinguish 4 subgroups of intracranial ependymomas, including supratentorial (ST) ependymomas with Yes-associated protein 1 fusion (YAP1), ST ependymomas with fusion of v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA), posterior fossa ependymomas with balanced genome, and posterior fossa ependymomas with chromosomal instability. In addition, trisomy 19 is a genomic hallmark of ependymomas with rich branching capillaries. However, the relation of histological and molecular subtypes is unclear. Here, we report a series of 20 ependymomas histologically defined by clear cells and branching capillaries. We observed a strong male predominance. Median age at surgery was 10.4 years (range, 0.8–68.4). All cases were ST, cortical, contrast enhancing, and most often frontal, cystic, and calcified. All tumors qualified as WHO grade III. Some of them exhibited neuronal differentiation. Trisomy 19 was recorded in 13 cases. All samples strongly accumulated p65RelA protein within nuclei, indicating pathological activation of the nuclear factor-kappaB pathway. We identified causative C11ORF95-RELA fusion in almost all cases. Median progression-free survival and overall survival were 11.4 years (95% CI: 5.1–17.8) and not reached, respectively. ST clear cell ependymomas with branching capillaries display characteristic clinicopathological features and are associated with pathological activation of nuclear factor-kappaB signaling, which may indicate a potential novel target for therapy in these patients.